Association Between Carotid Plaque Length and Cardiovascular Outcomes

April 25, 2023 updated by: Changhai Hospital
This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 5000 consecutive patients without known CAD who underwent first coronary angiography for stable chest pain and carotid ultrasound was performed during hospitalization from January 2017 through December 2018.

Study Overview

Status

Active, not recruiting

Detailed Description

Patients who had obstructive CAD (defined as ≥50% luminal stenosis) confirmed by coronary angiography and who underwent carotid scanning were included in the final analysis.Carotid ultrasonography was performed simultaneously, and carotid intima-media thickness (IMT), maximum thickness and length of all plaques were measured.The incidence of major adverse cardiovascular events was recorded during follow-up.

Study Type

Observational

Enrollment (Anticipated)

3000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Wuxi, Jiangsu, China, 214000
        • No. 904 Hospital of the PLA Joint Logistics Support Force
    • Shanghai
      • Shanghai, Shanghai, China, 200000
        • Changhai Hospital
      • Shanghai, Shanghai, China, 200000
        • Gongli Hospital
      • Shanghai, Shanghai, China, 200000
        • Putuo Hospital
      • Shanghai, Shanghai, China, 200000
        • Yueyang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Consecutive patients without known CAD who underwent first coronary angiography for stable chest pain and carotid ultrasound was performed during hospitalization.

Description

Inclusion Criteria:

  • Patients who underwent coronary angiography for stable chest pain and carotid ultrasound simultaneously;
  • Patients with obstructive CAD (≥50% coronary stenosis);

Exclusion Criteria:

  • <18 years of age;
  • previous carotid surgery or significant carotid artery disease;
  • prior stroke or transient ischemic attack;
  • previously documented CAD (including history of myocardial infarction, acute coronary syndrome, or coronary revascularization);

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Carotid plaque length
Patients underwent carotid ultrasonography and first coronary angiography simultaneously

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
major adverse cardiovascular events
Time Frame: 3 years
cardiovascular death, myocardial infarction, ischemic stroke and coronary revascularization
3 years

Secondary Outcome Measures

Outcome Measure
Time Frame
all-cause death
Time Frame: 3 years
3 years
cardiovascular death
Time Frame: 3 years
3 years
myocardial infarction
Time Frame: 3 years
3 years
ischemic stroke
Time Frame: 3 years
3 years
coronary artery revascularization
Time Frame: 3 years
3 years
heart failure
Time Frame: 3 years
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pan Li, PhD, Changhai Hospital
  • Study Director: Liang Chen, MD, No. 904 Hospital of the PLA Joint Logistics Support Force
  • Study Director: Wei Zhang, MD, Gongli Hospital
  • Study Director: Yawei Yang, MD, Yueyang Hospital
  • Study Director: Jian Jian Na, MD, Putuo Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

March 31, 2022

Study Completion (Anticipated)

December 31, 2030

Study Registration Dates

First Submitted

April 25, 2023

First Submitted That Met QC Criteria

April 25, 2023

First Posted (Estimate)

May 4, 2023

Study Record Updates

Last Update Posted (Estimate)

May 4, 2023

Last Update Submitted That Met QC Criteria

April 25, 2023

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

3
Subscribe